Charlie Hospital Semarang Tbk. vs Unilever Indonesia Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Unilever Indonesia Tbk. trades at Rp1,710 (market cap 66.19T, 17.49M 24h volume). The key difference: Unilever Indonesia Tbk. is far larger — about 89.2× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 17.49M). Which is the better fit depends on your goals.
| RSCH | UNVR | |
|---|---|---|
Market Cap | 742B | 66.19T |
Volume | 29.45M | 17.49M |
Lot | 294.49K | 174.92K |
Turnover | 8.14B | 30.1B |
Average Price | 276.35 | 1,720.92 |
Value | 8.14B | 30.1B |
Indicative Equilibrium Price | 270 | 1,710 |
Indicative Equilibrium Volume | 103 | 13.43K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Unilever Indonesia Tbk (the Company) was established on 5 December 1933 as Levers Zeepfabrieken N.V. by deed No. 23 of Mr. A.H. van Ophuijsen, a notary in Batavia, which was approved by the Gouverneur Generaal van Nederlandsch-Indie in letter No. 14 on 16 December 1933, registered at the Raad van Justitie in Batavia under No. 302 on 22 December 1933 and published in the Javasche Courant on 9 January 1934, Supplement No. 3.
Read more on UNVR →